Britain virus covid-19 vaccine Britain

UK health regulators approve drug to tackle new Omicron variant of Covid-19

Reading now: 861
www.manchestereveningnews.co.uk

UK regulators have approved a drug treatment to tackle the new Omicron variant of Covid-19. The drug, known as Xevudy (sotrovimab, and made by pharmaceutical giant GlaxoSmithKline (GSK), has been found to cut hospital admission and death by 79 per cent for those at risk.

The medicines and Healthcare products Regulatory Agency has authorised the monoclonal antibody for people with mild to moderate Covid-19 who are at high risk of suffering from complications with the disease. Read more: It comes as GSK and Vir Biotechnology said preclinical data shows the drug “retains activity against key mutations of the new Omicron Sars-CoV-2 variant”.

Read more on manchestereveningnews.co.uk
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA